Top stock picks from Wall Street's No. 1 biotech analyst

Wall Street's No. 1 biotech analyst Umer Raffat has two names at the top of his buy list — Allergan and Dermira.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.